Novavax, Inc. (NVAX), CPLB and ICGEB Collaboration Honored for Malaria Vaccine Progress at Vaccine World Summit India 2013  
3/8/2013 10:19:35 AM

ROCKVILLE, Md., March 8, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that its collaboration to develop a novel malaria vaccine in India has been honored by the Vaccine World Summit India 2013 conference for having the "Most Promising Vaccine for Emerging Diseases in India." This competitive award recognized the progress made by Novavax, Cadila Pharmaceuticals Ltd. Biologicals (CPLB) and the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a new and effective malaria vaccine. It was one of five inaugural awards honoring achievements in India's vaccine industry.